Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price · Investor's Business Daily

In This Article:

Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition.